(19)
(11) EP 2 444 019 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
02.01.2019 Bulletin 2019/01

(45) Mention of the grant of the patent:
14.11.2018 Bulletin 2018/46

(21) Application number: 12151275.0

(22) Date of filing: 27.04.2011
(51) International Patent Classification (IPC): 
A61B 18/14(2006.01)
A61B 17/00(2006.01)
 A61B 18/00(2006.01)

(54)

Irrigated ablation catheter with improved fluid flow

Ablationskatheter mit verbessertem Flüssigkeitsfluss

Cathéter d'ablation irrigué avec débit de fluide amélioré

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 28.04.2010 US 769592
29.04.2010 US 770582

(43) Date of publication of application:
25.04.2012 Bulletin 2012/17

(62) Application number of the earlier application in accordance with Art. 76 EPC:
11163898.7 / 2382935

(73) Proprietor: Biosense Webster, Inc.
Irvine, CA 92618 (US)

(72) Inventors:
  • Clark, Jeffrey
    Castaic, CA California 91384 (US)
  • Brichard, Christopher
    Newport Coast, CA 92657 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
EP-A1- 1 690 510
EP-A1- 2 380 519
US-A- 5 545 161
 EP-A1- 2 145 596
WO-A1-2011/081685
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).